MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2
Publicado el 9 de agosto de 2017 · Inicio del retiro: 22 de mayo de 2017
Resumen
FDA registra el retiro Z-2867-2017 de dispositivos médicos de Clase II, publicado el 9 de agosto de 2017 e iniciado el 22 de mayo de 2017. Empresa responsable: Sentinel CH SPA; Estado: Finalizado; Cantidad reportada: 2356 kits Worldwide; US 206 kits; Lote: Catalog Number 8L24-31: Lot Numbers: 60335Y600, 60382Y600 (Exp. Date 2018-02-28); Catalog Number 8L24-41: Lot Number: 60334Y600, (Exp. Date 2018-02-28). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Sentinel CH SPA
- Distribuidor
- Nationwide Distribution
- Lote
- Catalog Number 8L24-31: Lot Numbers: 60335Y600, 60382Y600 (Exp. Date 2018-02-28); Catalog Number 8L24-41: Lot Number: 60334Y600, (Exp. Date 2018-02-28)
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Italy
Retiros relacionados
- FDAGlipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per16 de agosto de 2017
- FDATomcat Instrument, REF ASY-07379, Hologic Incorporated, automated laboratory sample processing instrument.9 de agosto de 2017
- FDAROSA Brain, 3.0.0 The device is intended for the spatial positioning and orientation of instrument holders or9 de agosto de 2017
- FDAInflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for9 de agosto de 2017
- FDANon-Locking screws in the following lengths: (a) NEO(R) 0.27 - 10 mm, REF W27 ST010 (b) NEO(R) 0.27 - 12 mm,9 de agosto de 2017
- FDAStroke Fast Pack(TM) Trevo XP ProVue Retriever 4 x 30, Trevo Pro 18 Microcatheter, AXS Catalyst 060x132CM -9 de agosto de 2017
Preguntas sobre este retiro
¿MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2 fue retirado del mercado?
Sí. FDA publicó el retiro Z-2867-2017 el 9 de agosto de 2017. Peligro reportado: Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter